Zhongzhi Pharmaceutical Holdings (HKSE:03737) Dividend Payout Ratio : 1.69 (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Zhongzhi Pharmaceutical Holdings Dividend Payout Ratio?

Zhongzhi Pharmaceutical Holdings's dividend payout ratio for the months ended in Dec. 2023 was 1.69.

The historical rank and industry rank for Zhongzhi Pharmaceutical Holdings's Dividend Payout Ratio or its related term are showing as below:

HKSE:03737' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.26 Med: 0.49 Max: 0.65
Current: 0.58

During the past 10 years, the highest Dividend Payout Ratio of Zhongzhi Pharmaceutical Holdings was 0.65. The lowest was 0.26. And the median was 0.49.

HKSE:03737's Dividend Payout Ratio is ranked worse than
74.06% of 424 companies
in the Drug Manufacturers industry
Industry Median: 0.335 vs HKSE:03737: 0.58

As of today (2024-06-03), the Dividend Yield % of Zhongzhi Pharmaceutical Holdings is 8.65%.

During the past 10 years, the highest Trailing Annual Dividend Yield of Zhongzhi Pharmaceutical Holdings was 12.10%. The lowest was 1.62%. And the median was 3.93%.

Zhongzhi Pharmaceutical Holdings's Dividends per Share for the months ended in Dec. 2023 was HK$0.06.

During the past 3 years, the average Dividends Per Share Growth Rate was 31.70% per year.

During the past 10 years, the highest 3-Year average Dividends Per Share Growth Rate of Zhongzhi Pharmaceutical Holdings was 31.70% per year. The lowest was 11.00% per year. And the median was 22.30% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Zhongzhi Pharmaceutical Holdings Dividend Payout Ratio Historical Data

The historical data trend for Zhongzhi Pharmaceutical Holdings's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhongzhi Pharmaceutical Holdings Dividend Payout Ratio Chart

Zhongzhi Pharmaceutical Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dividend Payout Ratio

Get a 7-Day Free Trial

0.45

0.28

0.58

Zhongzhi Pharmaceutical Holdings Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Dividend Payout Ratio	Get a 7-Day Free Trial															-	-	-	0.35	1.69

Competitive Comparison of Zhongzhi Pharmaceutical Holdings's Dividend Payout Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Zhongzhi Pharmaceutical Holdings's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zhongzhi Pharmaceutical Holdings's Dividend Payout Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhongzhi Pharmaceutical Holdings's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Zhongzhi Pharmaceutical Holdings's Dividend Payout Ratio falls into.

Zhongzhi Pharmaceutical Holdings Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Zhongzhi Pharmaceutical Holdings's Dividend Payout Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Dec. 2023 )	/	EPS without NRI (A: Dec. 2023 )
	=	0.121	/	0.208
	=	0.58

Zhongzhi Pharmaceutical Holdings's Dividend Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Dec. 2023 )	/	EPS without NRI (Q: Dec. 2023 )
	=	0.061	/	0.036
	=	1.69

Zhongzhi Pharmaceutical Holdings (HKSE:03737) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Zhongzhi Pharmaceutical Holdings Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Zhongzhi Pharmaceutical Holdings's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhongzhi Pharmaceutical Holdings (HKSE:03737) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhongzhi Pharmaceutical Holdings Ltd (HKSE:03737) » Definitions » Dividend Payout Ratio

Traded in Other Exchanges

N/A

Address

No. 3 Kangtai Road South, Torch Development Zone, Guangdong Province, Zhongshan, CHN

Website

https://www.zeus.cn

Zhongzhi Pharmaceutical Holdings Ltd is engaged in the business of manufacturing and selling pharmaceutical products. The group's operations can be divided into three segments, namely Pharmaceutical manufacturing, Operation of chain pharmacies, and Operation of online pharmacies in Zhongshan in the Guangdong province, the PRC. In the Pharmaceutical manufacturing segment, the company is engaged in the research and development, manufacturing and sale of Chinese patent medicines. In the Operation of chain pharmacies segment, the firm operates chain pharmacies in Zhongshan under the brand Zeus for the sale of pharmaceutical products. The Operation of online pharmacies segment sells medicines online. It derives a majority of its revenue from the PRC.

Executives

Jiang Li Xia	2202 Interest of your spouse
Lai Zhi Tian	2201 Interest of corporation controlled by you
Crystal Talent Investment Group Limited	2101 Beneficial owner
Cheng Jin Le	2201 Interest of corporation controlled by you
Advance Keypath Global Investment Limited	2101 Beneficial owner
Novich Positioning Investment (cayman) Limited	2201 Interest of corporation controlled by you
Novich Positioning Investment Limited Partnership	2101 Beneficial owner

Zhongzhi Pharmaceutical Holdings (HKSE:03737) Headlines

No Headlines